GlobeNewswire Inc.·Mar 12·Not SpecifiedSIXR Taps Cricket Legends Gayle, Afridi to Build Fan Engagement PlatformSIXR digital cricket platform names Chris Gayle and Shahid Afridi as Icon Players ahead of beta game launch in H2 2026. ASIXfan engagementgaming
GlobeNewswire Inc.·Mar 12·ClaimsfilerUltragenyx Stock Collapses 42% After Clinical Trial Failure, Class Action Deadline LoomsUltragenyx Pharmaceutical's stock plunged 42% after failing to disclose setrusumab Phase 3 trial failure, triggering securities litigation with April 6, 2026 lead plaintiff deadline. RAREsecurities fraudclass action lawsuit
The Motley Fool·Mar 12·Reuben Gregg BrewerOil Surge Roils Markets as Middle East Tensions Spike; Long-Term Investors Eye OpportunitiesMiddle East tensions drive oil prices higher, triggering market volatility. Energy spikes historically prove temporary; investors should prepare to buy quality stocks at discounted prices. FANGDLTRmarket volatilitylong-term investing
GlobeNewswire Inc.·Mar 12·Rosen Law FirmBellRing Brands Faces Securities Lawsuit Over Misrepresented Organic Growth ClaimsBellRing Brands faces securities lawsuit alleging it misrepresented sales growth as organic when driven by inventory stockpiling, with a March 23, 2026 deadline for investors to join. BRBRsecurities class actionlead plaintiff deadline
The Motley Fool·Mar 12·Steven PorrelloBloom Energy's AI Boom: Can $BE Sustain Its 556% Rally to $200?Bloom Energy stock surged 556% annually on AI data center demand, but $200 target faces headwinds: only $1.1M quarterly profit on $777M revenue at 16x sales valuation. WMTORCLORCLpDVZEQIX+2stock valuationprofitability concerns
The Motley Fool·Mar 12·Jonathan PoncianoClifford Capital Bets $14M on WEX as Fintech Posts Record $2.7B RevenueClifford Capital Partners acquires $14.2M stake in WEX as fintech reports record $2.66B revenue and $304.1M profit, yet stock remains flat versus S&P 500's 20% gain. RKTWEXSOLVfintechinstitutional investment
GlobeNewswire Inc.·Mar 12·Rosen Law FirmKDDI Faces Securities Investigation Over Delayed Earnings, Stock Plunges 11.4%Rosen Law Firm investigates KDDI for allegedly misleading investors. Stock fell 11.4% after company postponed earnings disclosure due to internal investigation. KDDIYsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 12·Sns InsiderRetail Tech Boom: On-Shelf Availability Market to Hit $16B by 2035Global on-shelf availability solutions market projected to grow 144% from $6.56B in 2025 to $16.02B by 2035, driven by AI and IoT adoption. ORCLORCLpDSAPIBMHON+1inventory managementretail technology
GlobeNewswire Inc.·Mar 12·The Rosen Law FirmNidec Stock Plunges 23% on China Accounting Probe; Investors Eye Legal ActionNidec stock plunges 22.7% after announcing China accounting probe; law firms investigating securities fraud claims for affected investors. NJDCYsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 12·UnknownPepeto Launches Zero-Fee Trading Platform as Crypto Sector Pursues DeFi InnovationPepeto launches zero-fee DEX across Ethereum, BNB Chain, and Solana with AI security features, securing $7.9M in presale funding. XRPCXRPPepeto
GlobeNewswire Inc.·Mar 12·NaFirefly Aerospace Validates Block II Upgrades With Successful Alpha Flight 7Firefly Aerospace successfully tested Block II upgrades on Alpha Flight 7, validating new avionics and thermal systems ahead of the enhanced Block II configuration featuring a 7-foot length increase. LMTFLYspace technologylaunch vehicle
GlobeNewswire Inc.·Mar 12·Rosen Law FirmHub Group Accounting Error Sparks 18% Stock Plunge, Legal ScrutinyHub Group discloses accounting error understating costs, triggering 18.3% stock plunge and securities litigation investigation. HUBGsecurities fraudclass action lawsuit
The Motley Fool·Mar 12·Jeremy BowmanAxon Enterprise Eyes $8B Revenue Goal as AI Products Drive Growth MomentumAxon Enterprise reports 33% revenue growth to $2.8B in 2025, launching AI tools like Draft One and Axon Assistant while targeting $8B revenue by 2028. NVDAAXONrevenue growthartificial intelligence
The Motley Fool·Mar 12·Jonathan PoncianoTax Season Contrarian: Lodge Hill Bets $35M on Beaten-Down H&R BlockLodge Hill Capital builds significant $35M position in H&R Block despite 40% stock decline, signaling confidence in tax preparation giant's fundamentals. RKTHRBstock declineinstitutional investment
GlobeNewswire Inc.·Mar 12·Rosen Law FirmSnowflake Faces Securities Class Action Over Undisclosed Product ImpactRosen Law Firm alerts $SNOW investors of April 27, 2026 deadline in class action alleging undisclosed negative impacts from product efficiency gains. SNOWsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.·Mar 12·NaGlobalFoundries to Buy Back $300M in Stock as Mubadala Offloads 20M SharesGlobalFoundries announced a $300M share repurchase concurrent with Mubadala's $840M secondary offering of 20M shares at $42 each, closing March 13, 2026. GFScapital allocationshare repurchase
GlobeNewswire Inc.·Mar 12·ClaimsfileruniQure Stock Crashes 49% on FDA Setback; Class Action Deadline LoomsuniQure faces securities lawsuit after FDA rejected AMT-130 approval pathway. Stock plummeted 49% following disclosure. Lead plaintiff deadline: April 13, 2026. QUREsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.·Mar 12·ClaimsfilerKyndryl Faces Major Securities Lawsuit After 55% Stock Collapse on Control FailuresKyndryl Holdings faces securities class action over undisclosed internal control weaknesses. Stock plunged 55% after February 2026 disclosure; lead plaintiff deadline set for April 13. KDsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 12·ClaimsfilerEnphase Energy Faces Securities Lawsuit Over Inventory DisclosuresEnphase Energy faces class action lawsuit over alleged material misstatements regarding inventory management and tax credit impacts. Lead plaintiff deadline set for April 20, 2026. ENPHsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 12·Claimsfiler$CORT Plummets 50% After FDA Rejection; Class Action Deadline Looms for Major Shareholders$CORT stock plummets 50% after FDA rejects lead drug relacorilant; class action targets alleged disclosure failures with lead plaintiff deadline April 21, 2026. CORTsecurities fraudclass action lawsuit